tiprankstipranks
Trending News
More News >
Lincoln Pharmaceuticals Ltd (IN:LINCOLN)
:LINCOLN
India Market

Lincoln Pharmaceuticals Ltd (LINCOLN) Financial Statements

Compare
2 Followers

Lincoln Pharmaceuticals Ltd Financial Overview

Lincoln Pharmaceuticals Ltd's market cap is currently ₹11.24B. The company's EPS TTM is ₹5.78; its P/E ratio is 13.65; and it has a dividend yield of 0.32%. Lincoln Pharmaceuticals Ltd is scheduled to report earnings on May 22, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 6.23B₹ 5.81B₹ 5.05B₹ 4.68B₹ 4.15B
Gross Profit₹ 3.32B₹ 3.01B₹ 2.59B₹ 2.46B₹ 2.13B
Operating Income₹ 885.94M₹ 1.91B₹ 806.75M₹ 883.99M₹ 798.01M
EBITDA₹ 1.24B₹ 1.34B₹ 1.12B₹ 1.05B₹ 928.43M
Net Income₹ 823.46M₹ 933.05M₹ 728.99M₹ 693.55M₹ 622.50M
Balance Sheet
Cash & Short-Term Investments₹ 1.97B₹ 1.52B₹ 1.08B₹ 1.15B₹ 921.10M
Total Assets₹ 7.97B₹ 7.00B₹ 5.87B₹ 5.34B₹ 4.52B
Total Debt₹ 0.00₹ 10.67M₹ 19.97M₹ 20.44M₹ 5.20M
Net Debt₹ -134.14M₹ -46.80M₹ -30.55M₹ -48.90M₹ -109.19M
Total Liabilities₹ 1.25B₹ 1.07B₹ 849.46M₹ 1.01B₹ 859.67M
Stockholders' Equity₹ 6.72B₹ 5.93B₹ 5.02B₹ 4.33B₹ 3.66B
Cash Flow
Free Cash Flow₹ 737.71M₹ 236.04M₹ 249.80M₹ 306.07M₹ 605.19M
Operating Cash Flow₹ 930.15M₹ 632.17M₹ 392.62M₹ 761.32M₹ 692.70M
Investing Cash Flow₹ -789.47M₹ -573.42M₹ -366.43M₹ -780.80M₹ -642.27M
Financing Cash Flow₹ -64.02M₹ -51.80M₹ -45.01M₹ -25.56M₹ -57.45M
Currency in INR

Lincoln Pharmaceuticals Ltd Earnings and Revenue History

Lincoln Pharmaceuticals Ltd Debt to Assets

Lincoln Pharmaceuticals Ltd Cash Flow

Lincoln Pharmaceuticals Ltd Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis